Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Ann Surg Oncol. 2013 Oct 12;21(2):643–649. doi: 10.1245/s10434-013-3313-y

Table 4.

Survival in Patients with Positive and False Negative SLNB.

Overall, N (% of metastatic nodes) Died of Disease, N (%) 5-year Disease-Specific Survival
False Negative SLNB 5 (15) 2 (40) 60%
Positive SLNB 29 (85) 4 (14) 88%